In addition, circRNA cMras could inhibit lung adenocarcinoma progression by interacting with alpha-beta hydrolase domain 5 (ABHD5) and adipose triglyceride lipase (ATGL) through the NF-κB signaling pathway [156]. The gene discussed is PNPLA2; the disease is lung adenocarcinoma.